Analysis of the clinical distribution of Acinetobacter baumannii infection and its drug resistance
10.3760/cma.j.issn.1008-6706.2015.09.024
- VernacularTitle:浙江省乐清市第二人民医院鲍曼不动杆菌感染的临床分布情况及其耐药分析
- Author:
Gaofeng YE
;
Suijuan ZHAO
- Publication Type:Journal Article
- Keywords:
Acinetobacter baumannii;
Infection
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;22(9):1348-1350
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical distribution of Acinetobacter Baumann in our hospital and its drug resistance,provide a reference for clinical medical thereby.Methods A retrospectively analysis for 406 Acinetobacter baumannii detected in our hospital from January 2010 to January 2012 was made,the clinical distribution was observed,and the resistance rates of several commonly used antimicrobial agents was calculated.Results Acinetobacter baumannii infections was mainly detected in respiratory medicine and intensive care unit,the detection rate were 27.3％ and 19.0％,the primarily infection site was the respiratory system,Acinetobacter baumannii was detected mainly from sputum specimens and the detection rate was 56.2％,the resistance rate of imipenem,meropenem and cefoperazone sulbactam was relatively low,which were 8.6％,10.6％ and 17.0％.Conclusion Acinetobacter baumannii is an important cause of nosocomial infections and prone to multidrug-resistant pathogens,it is a serious threat to patients,we must make a strict selection of appropriate antibiotic therapy based on susceptibility to reduce nosocomial transmission of Acinetobacter baumannii.
